Skip to content
Search

Latest Stories

SaveourPharmacies: Two thirds of pharmacies forced to slash opening hours due to funding squeeze

SaveourPharmacies: Two thirds of pharmacies forced to slash opening hours due to funding squeeze
Pharmacy protest unveils as up to 6000 pharmacies through NPA have called for a day of action against financial crisis burdening the sector

"Cutting opening hours is a last resort for pharmacies desperately trying to make ends meet in the face of a decade of cuts," Paul Rees, Chief Executive of the National Pharmacy Association(NPA) has stated.

Amidst unprecedented closures and financial strain, up to 6,000 community pharmacies across the UK unite in protest today, underscoring a decade of funding cuts that have forced two-thirds to slash operating hours, highlighting a sector in crisis.


The unprecedented day of action is symbolized by dimming lights and wearing black to protest against the deteriorating financial conditions.

According to new analysis by the NPA, approximately 63 per cent of pharmacies have been compelled to reduce their opening hours since 2015 due to extreme financial pressures.

This translates to an average reduction of 6.1 hours per pharmacy, amounting to a 10 per cent decrease in accessibility for patients.

The analysis further reveals that only a minuscule 2.5 per cent of pharmacies managed to increase their operating hours during this period.

In 2015, pharmacies were open an average of 54.2 hours per week, a number that has dwindled to 48.1 hours by 2024.

Additionally, nearly 5 per cent of pharmacies included in the study were forced to shut down completely.

Funding for pharmacies in England alone has plummeted by 40 per cent in real terms over the past decade, pushing many establishments to the brink of closure.

Paul Rees, Chief Executive of the NPA, conveyed the gravity of the situation, stating, "The current situation is unsustainable and, with three-quarters of pharmacies in the red, many are simply being pushed to the brink."

He emphasized the dire consequences, noting that 1,400 pharmacies have shut down in England alone over the last ten years, with similar closures in Wales and Northern Ireland, and impending risks in Scotland.

The NPA's February survey underscored that 64 per cent of pharmacy owners are tapping into personal savings or family support to sustain their businesses, with 79 per cent reporting inadequate remuneration for their work.

This financial strain is exacerbated by the fact that pharmacy funding no longer covers the costs of many medicines, forcing pharmacies to dispense medication at a loss.

Rees highlighted the urgency for political intervention, calling for a new funding framework that allocates at least 2.5 per cent of the overall NHS budget to pharmacies.

The NPA's day of action aims to draw attention to these issues, urging all political parties to commit to ending funding reductions and ensuring a sustainable future for community pharmacies.

More For You

Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.

Keep ReadingShow less
Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less
NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

NICE seeks feedback on annual BMI checks for adults with long-term conditions

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.

Keep ReadingShow less
Medicine shortages: Penny-pinching costs taxpayers more, warns CCA

Pharmacies are forced to dispense medicines at a loss or face stock shortages.

Getty Images

Government’s penny-pinching approach driving medicine shortages, CCA warns

The Company Chemists’ Association (CCA) has warned the government's longstanding drive to save pennies on the medicines bill is leading to avoidable medicine shortages, ultimately costing taxpayers more.

In a newly released paper, the CCA highlighted how the government has squeezed the price it is willing to pay for many medicines, making the UK a less attractive market for pharmaceutical manufacturers and suppliers.

Keep ReadingShow less